These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29947113)

  • 1. Use of Endoglycosidase H as a diagnostic tool for MAN1B1-CDG patients.
    Duvet S; Mouajjah D; Péanne R; Matthijs G; Raymond K; Jaeken J; Morava E; Foulquier F
    Electrophoresis; 2018 Dec; 39(24):3133-3141. PubMed ID: 29947113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency.
    Saldova R; Stöckmann H; O'Flaherty R; Lefeber DJ; Jaeken J; Rudd PM
    J Proteome Res; 2015 Oct; 14(10):4402-12. PubMed ID: 26401844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAN1B1-CDG: Three new individuals and associated biochemical profiles.
    Sakhi S; Cholet S; Wehbi S; Isidor B; Cogne B; Vuillaumier-Barrot S; Dupré T; Detleft T; Schmitt E; Leheup B; Bonnet C; Feillet F; Muti C; Fenaille F; Bruneel A
    Mol Genet Metab Rep; 2021 Sep; 28():100775. PubMed ID: 34141584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical glycomics for the diagnosis of congenital disorders of glycosylation.
    Abu Bakar N; Lefeber DJ; van Scherpenzeel M
    J Inherit Metab Dis; 2018 May; 41(3):499-513. PubMed ID: 29497882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
    Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
    Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.
    Abu Bakar N; Ashikov A; Brum JM; Smeets R; Kersten M; Huijben K; Keng WT; Speck-Martins CE; de Carvalho DR; de Rizzo IMPO; de Mello WD; Heiner-Fokkema R; Gorman K; Grunewald S; Michelakakis H; Moraitou M; Martinelli D; van Scherpenzeel M; Janssen M; de Boer L; van den Heuvel LP; Thiel C; Lefeber DJ
    J Inherit Metab Dis; 2022 Jul; 45(4):769-781. PubMed ID: 35279850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAN1B1-CDG: novel patients and novel variant.
    Kasapkara CS; Olgac A; Kilic M; Keldermans L; Matthijs G; Jaeken J
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1207-1209. PubMed ID: 34162022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siblings with MAN1B1-CDG Showing Novel Biochemical Profiles.
    Okamoto N; Ohto T; Enokizono T; Wada Y; Kohmoto T; Imoto I; Haga Y; Seino J; Suzuki T
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
    Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
    Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
    Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
    Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HILIC-UPLC-MS for high throughput and isomeric N-glycan separation and characterization in Congenital Disorders Glycosylation and human diseases.
    Messina A; Palmigiano A; Esposito F; Fiumara A; Bordugo A; Barone R; Sturiale L; Jaeken J; Garozzo D
    Glycoconj J; 2021 Apr; 38(2):201-211. PubMed ID: 32915358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).
    Casetta B; Malvagia S; Funghini S; Martinelli D; Dionisi-Vici C; Barone R; Fiumara A; Donati MA; Guerrini R; la Marca G
    Clin Chem Lab Med; 2020 Aug; 59(1):165-171. PubMed ID: 32776892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies.
    Zhang W; James PM; Ng BG; Li X; Xia B; Rong J; Asif G; Raymond K; Jones MA; Hegde M; Ju T; Cummings RD; Clarkson K; Wood T; Boerkoel CF; Freeze HH; He M
    Clin Chem; 2016 Jan; 62(1):208-17. PubMed ID: 26430078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.
    Wada Y
    Mass Spectrom (Tokyo); 2020; 9(1):A0084. PubMed ID: 32547898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency.
    Van Scherpenzeel M; Timal S; Rymen D; Hoischen A; Wuhrer M; Hipgrave-Ederveen A; Grunewald S; Peanne R; Saada A; Edvardson S; Grønborg S; Ruijter G; Kattentidt-Mouravieva A; Brum JM; Freckmann ML; Tomkins S; Jalan A; Prochazkova D; Ondruskova N; Hansikova H; Willemsen MA; Hensbergen PJ; Matthijs G; Wevers RA; Veltman JA; Morava E; Lefeber DJ
    Brain; 2014 Apr; 137(Pt 4):1030-8. PubMed ID: 24566669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS--application to rheumatoid arthritis.
    Frisch E; Kaup M; Egerer K; Weimann A; Tauber R; Berger M; Blanchard V
    Electrophoresis; 2011 Dec; 32(24):3510-5. PubMed ID: 22180205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis.
    Wang Y; Tan J; Sutton-Smith M; Ditto D; Panico M; Campbell RM; Varki NM; Long JM; Jaeken J; Levinson SR; Wynshaw-Boris A; Morris HR; Le D; Dell A; Schachter H; Marth JD
    Glycobiology; 2001 Dec; 11(12):1051-70. PubMed ID: 11805078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.